Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
UNITED THERAPEUTICS Corp roe for the quarter ending 2026-06-30 was 20.48%, a 18.29% increase year-over-year.
UNITED THERAPEUTICS Corp roe for the quarter ending 2026-03-31 was 21.82%, a 22.66% increase year-over-year.
UNITED THERAPEUTICS Corp roe for the quarter ending 2025-12-31 was 18.81%, a 1.42% increase year-over-year.
UNITED THERAPEUTICS Corp roe for the quarter ending 2025-09-30 was 19.30%, a 5.98% increase year-over-year.
UNITED THERAPEUTICS Corp roe for fiscal 2025 was 18.81%, a 1.42% increase from fiscal 2024.
UNITED THERAPEUTICS Corp roe for fiscal 2024 was 18.55%, a 12.71% increase from fiscal 2023.
UNITED THERAPEUTICS Corp roe for fiscal 2023 was 16.46%, a 8.52% increase from fiscal 2022.
UNITED THERAPEUTICS Corp roe for fiscal 2022 was 15.16%, a 26.16% increase from fiscal 2021.